Temaz and Emla drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Temaz (temazepam) and Emla (lidocaine; prilocaine). Common drug interactions include malaise among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Temaz and Emla. It is created by eHealthMe based on reports of 46 people who take the same drugs from the FDA, and is updated regularly.

What is Temaz?

Temaz has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,293 Temaz users. Check the latest studies of Temaz.

What is Emla?

Emla has active ingredients of lidocaine; prilocaine. eHealthMe is studying from 5,276 Emla users. Check the latest studies of Emla.



On Aug, 01, 2026

46 people who take Temaz and Emla together, and have interactions are studied.

Temaz and Emla drug interactions.

What are the common drug interactions of Temaz and Emla, by gender? *:

female:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Rash erythematous (redness of the skin)
  4. Renal failure (kidney dysfunction)
  5. Urticaria (rash of round, red welts on the skin that itch intensely)
  6. Weight decreased
  7. Abdominal wall haematoma (abdominal wall blood clotting)
  8. Alanine aminotransferase increased
  9. Alopecia (absence of hair from areas of the body)
  10. Aphthous stomatitis (mouth ulcer)

male:

  1. Pneumonia
  2. Anaemia (lack of blood)
  3. Abdominal pain
  4. Abdominal pain upper
  5. Abnormal behaviour
  6. Activated partial thromboplastin time prolonged
  7. Aggression
  8. Arrhythmia (irregular heartbeat)
  9. Asthenia (weakness)
  10. Bipolar disorder (mood disorder)

What are the common drug interactions of Temaz and Emla, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Dyspnoea (difficult or laboured respiration)
  2. Oedema mouth (swelling of mouth)
  3. Anaphylactic reaction (serious allergic reaction)
  4. Face oedema (swelling of face)
  5. Headache (pain in head)
  6. Rash erythematous (redness of the skin)
  7. Urticaria (rash of round, red welts on the skin that itch intensely)
  8. Erythema (redness of the skin)

10-19:

  1. Juvenile idiopathic arthritis (a subset of arthritis seen in childhood)

20-29:

n/a

30-39:

n/a

40-49:

  1. Nausea (feeling of having an urge to vomit)
  2. Abdominal pain upper
  3. Headache (pain in head)
  4. Infusion site swelling
  5. Intracranial pressure increased (high pressure inside the skull and thus in the brain tissue and cerebrospinal fluid)
  6. Meningitis aseptic (a condition that causes the membranes covering your brain and spinal cord to become inflamed)
  7. Migraine (headache)
  8. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  9. Throat irritation

50-59:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Malignant ascites (a condition in which a person with cancer has an accumulation of fluid in the abdomen)
  3. Memory impairment
  4. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  5. Nausea (feeling of having an urge to vomit)
  6. Non-cardiac chest pain
  7. Pain
  8. Panic attack
  9. Sedation
  10. Sexual dysfunction (difficulty experienced by an individual or a couple during any stage of a normal sexual activity)

60+:

  1. Chronic kidney disease
  2. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  3. Asthenia (weakness)
  4. Death
  5. Disease progression
  6. Dysgeusia (disorder of the sense of taste)
  7. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  8. Neutropenia (an abnormally low number of neutrophils)
  9. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  10. Pneumonitis (inflammation of the walls of the alveoli in the lungs)

What are the existing conditions these people have? *

  1. Pain: 8 people, 17.39%
  2. Constipation: 7 people, 15.22%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 13.04%
  4. High Blood Pressure: 5 people, 10.87%
  5. Ovarian Cancer (cancer of ovary): 5 people, 10.87%
  6. Nausea (feeling of having an urge to vomit): 5 people, 10.87%
  7. Multiple Myeloma (cancer of the plasma cells): 5 people, 10.87%
  8. Depression: 5 people, 10.87%
  9. Back Pain: 4 people, 8.70%
  10. Pulmonary Embolism (blockage of the main artery of the lung): 4 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Temaz and Emla?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Temaz and Emla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Temaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Emla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Temaz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Emla and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on temazepam and lidocaine; prilocaine (the active ingredients of Temaz and Emla, respectively), and Temaz and Emla (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: